Previous close | 18.18 |
Open | 19.14 |
Bid | 18.16 x 100 |
Ask | 18.31 x 100 |
Day's range | 17.84 - 19.56 |
52-week range | 11.27 - 22.48 |
Volume | |
Avg. volume | 119,553 |
Market cap | 1.635B |
Beta (5Y monthly) | 0.98 |
PE ratio (TTM) | 21.75 |
EPS (TTM) | 0.84 |
Earnings date | 09 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 23.42 |
Afya (AFYA) delivered earnings and revenue surprises of 17.02% and 6.19%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
NOVA LIMA, Brazil, May 09, 2024--Afya Limited (Nasdaq: AFYA; B3: A2FY34) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, reported today financial and operating results for the three-month period ended March 31, 2024 (first quarter 2024). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS).
NOVA LIMA, Brazil, May 02, 2024--Afya Limited (Nasdaq: AFYA; B3: A2FY34) ("Afya" or the "Company"), the leading medical education group and digital health services provider in Brazil, announced today that it has entered into a share purchase agreement for the acquisition, through its wholly-owned subsidiary Afya Participações S.A., of 100% of the total share capital of Unidom Participações S.A. ("Unidompedro" and "Faculdade Dom Luiz"), present in Salvador (BA), Luis Eduardo Magalhães (BA), Barre